ReviewBiomedicines2023

Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review.

Alexandros Leonidas Liarakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.